Dialectical Behavior Therapy for Men With Borderline Personality Disorder and Antisocial Behavior: A Clinical Trial

Abstract

In addition to suicidal behaviors, men with borderline personality disorder (BPD) often display antisocial behavior that could impair contacts with mental health services. While research has established effective treatments for women with BPD, this is not yet the case for men. The authors evaluated 12 months of dialectical behavior therapy (DBT) for 30 men with BPD and antisocial behavior, using a within-group design with repeated measurements. The authors found moderate to strong, statistically significant preto posttreatment reductions of several dysfunctional behaviors, including self-harm, verbal and physical aggression, and criminal offending (rate ratios 0.17-0.39). Symptoms of BPD and depression were also substantially decreased. The dropout rate was 30%, and completing participants reported high satisfaction with treatment and maintained their improvements at 1-year follow-up. The authors conclude that DBT could be an effective treatment alternative for men with BPD and antisocial behavior, and it merits future studies with more rigorous design.

Alcohol Use Disorder and Antisocial and Borderline Personality Disorders

“…However, for the reduction of substance-related symptoms, no difference was found between the dialectical behavior therapy group and the treatment as usual group 77. Although dialectical behavior therapy is primarily used for BPD, it was found to be acceptable in a clinical trial intended to treat men with both BPD and ASPD, most of whom also reported substance use 78. Rates of alcohol and substance use did not change substantially in this trial, however.…”

A mechanism-based group-psychotherapy approach to aggressive behaviour in borderline personality disorder: findings from a cluster-randomised controlled trial

“…Clinical characteristics at the time of inclusion are provided in Table 1. The sample was comparable with other clinical samples 6,40,41 in terms of symptom severity, psychiatric comorbidities, medication and age; thus, it represented a typical treatmentseeking BPD out-patient population of moderate severity, given some recently published trials showing higher ZAN and GAF scores. 39,42 Owing to the treatment focus on aggression, the Herpertz et al percentage of male participants was higher than in most clinical trials in BPD.…”

“…5 Pre-to post-treatment reduction of aggression, again measured with the M-OAS, followed a 1 year DBT treatment of patients with BPD and antisocial behaviour in a within-group design without comparator treatment. 6 Furthermore, anger decreased after DBT skills training as a standalone treatment but hostility did not. 7,8 Mentalisation-based therapy (MBT) reduced anger and hostility in out-patients with BPD and comorbid antisocial personality disorder when offered as weekly combined individual and group psychotherapy over 18 months compared with structured clinical management.…”

فاعلیة برنامج إرشادی سلوکی جدلی فی خفض السلوک الاندفاعی لدى طلاب الجامعة ذوی أعراض اضطراب الشخصیة الحدیة

“…‫ثبُ‬ ‫٣ْؼو‬ ‫ؽ٤ش‬ ‫ّ٢ء،‬ ًَ ‫ك٢‬ ‫مار٢‬ ‫ّؼٞه‬ ‫ُل٣ٚ‬ ٌ٤ُ ‫ٝأٗٚ‬ ‫اُؾلٝك‬ ‫ٓؼوكخ‬ ‫اُٞاهغ‬ ‫ك٢‬ ‫لواؽ‬ (Stratton et al, 2020;Wetterborg, et al, 2020 (Linehan, 1993a;Harley, et al, 2016;Rathu & Miller, 2014 (Koerner & Dimeff, 2007;Linehan, 1993a; (Harley, et al, 2016;Linehan, 1993a;Rathu & Miller, 2014 (Buerger, et al, 2019;Keefe, et al, 2020;Guillén Botella, et al, 2020;Mohamadizadeh et al, 2018;Wetterborg, et al, 2020 (Bohus, et al, 2007;Bohus, et al, 2009 Berenson, et al, 2016;Euler, ( Terzi, et al, Lepouriel, et al, 2019;Richmond et al 2020;-Richard 19;et al, 20 2017) ‫اَُِٞى‬ ‫فل٘‬ ‫ك٢‬ ‫اُغلُ٢‬ ‫اًَُِٞ٢‬ ‫اُؼ٬ط‬ ‫ػِ٠‬ ‫هبئٔخ‬ ‫ئهّبك٣خ‬ ‫ثوآظ‬ ‫ر٘بُٝذ‬ ‫كهاٍبد‬ ‫ٜٝٓ٘ب‬ ، ‫ٓضَ:‬ ‫اُؾل٣خ،‬ ‫اُْقٖ٤خ‬ ‫اٙطواة‬ ‫أػواٗ‬ ‫مٝ١‬ ‫ُلٟ‬ ‫ا٫ٗلكبػ٢‬ (Buerger, et al, 2019; Wetterborg, et al, 2020) ‫أٗٞاع‬ ‫ٓغ‬ ‫اُغلُ٢‬ ‫اًَُِٞ٢‬ ‫اُؼ٬ط‬ ‫ثٔوبهٗخ‬ ‫اٛزٔذ‬ ‫كهاٍبد‬ ‫ٜٝٓ٘ب‬ ، ‫(ٓضَ:‬ ‫اُؼ٬عبد‬ ٖٓ ‫أفوٟ‬ ‫طبد)‬ َّ ‫قط‬ ُ ‫ثبُٔ‬ ‫ٝاُؼ٬ط‬ ‫اُؼٞاٛق،‬ ‫ر٘ظ٤ْ‬ ‫ػِ٢‬ ‫ٝاُزله٣ت‬ ‫اُلٝائ٢،‬ ‫اُؼ٬ط‬ ‫ٓضَ:‬ ‫ا٫ٗلكبػ٢،‬ ‫اَُِٞى‬ ‫ُقل٘‬ (Keefe, et al, 2020;Guillén Botella, et al, 2020;Mohamadizadeh et al, 2018) . (Keefe, et al, 2020;Guillén Botella, et al, 2020;Mohamadizadeh et al, 2018) .…”